Search Results - "RINGE, Johann D" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial

Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial

by Glüer, Claus‐C, Marin, Fernando, Ringe, Johann D, Hawkins, Federico, Möricke, Rüdiger, Papaioannu, Nikolaos, Farahmand, Parvis, Minisola, Salvatore, Martínez, Guillermo, Nolla, Joan M, Niedhart, Christopher, Guañabens, Nuria, Nuti, Ranuccio, Martín‐Mola, Emilio, Thomasius, Friederike, Kapetanos, Georgios, Peña, Jaime, Graeff, Christian, Petto, Helmut, Sanz, Beatriz, Reisinger, Andreas, Zysset, Philippe K
Published in Journal of bone and mineral research (01.06.2013)

Get full text

Journal Article

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis

by Ringe, Johann D
Published in Patient preference and adherence (21.07.2010)

Get full text

Journal Article

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

by Ringe, Johann D., Möller, Gerd
Published in Rheumatology international (01.12.2009)

Get full text

Journal Article

$The effect of Vitamin D on falls and fractures$

The effect of Vitamin D on falls and fractures

by Ringe, Johann D.
Published in Scandinavian journal of clinical & laboratory investigation. Supplement (01.04.2012)

Get full text

Journal Article

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

by Cianferotti, Luisella, Cricelli, Claudio, Kanis, John A., Nuti, Ranuccio, Reginster, Jean-Y., Ringe, Johann D., Rizzoli, Rene, Brandi, Maria Luisa
Published in Endocrine (01.09.2015)

Get full text

Journal Article Web Resource

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol

by RINGE, Johann D, SCHACHT, Erich
Published in Rheumatology international (01.07.2004)

Get full text

Journal Article

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass

by Schacht, E., Ringe, Johann D.
Published in Rheumatology international (2012)

Get full text

Journal Article

An estimate of the survival benefit of improving vitamin D status in the adult German population

An estimate of the survival benefit of improving vitamin D status in the adult German population

by Zittermann, Armin, von Helden, Raimund, Grant, William, Kipshoven, Christoph, Ringe, Johann D
Published in Dermato-endocrinology (01.11.2009)

Get full text

Journal Article

$Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence$

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

by Eastell, Richard, Vrijens, Bernard, Cahall, David L, Ringe, Johann D, Garnero, Patrick, Watts, Nelson B
Published in Journal of bone and mineral research (01.07.2011)

Get full text

Journal Article

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

by Delmas, Pierre D, Vrijens, Bernard, Eastell, Richard, Roux, Christian, Pols, Huibert A. P, Ringe, Johann D, Grauer, Andreas, Cahall, David, Watts, Nelson B
Published in The journal of clinical endocrinology and metabolism (01.04.2007)

Get full text

Journal Article

Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy

Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy

by RINGE, Johann D, FABER, Herbert, FARAHMAND, Parvis
Published in Journal of bone and mineral metabolism (01.01.2006)

Get full text

Journal Article

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

by Ringe, Johann D., Farahmand, Parvis, Faber, Herbert, Dorst, Alfred
Published in Rheumatology international (2009)

Get full text

Journal Article

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

by Ringe, Johann D., Doherty, John G.
Published in Rheumatology international (01.05.2010)

Get full text

Journal Article

Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer

Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer

by Ringe, Johann D
Published in Bone (New York, N.Y.) (01.11.2007)

Get full text

Journal Article

Efficacy of strontium ranelate on bone mineral density in men with osteoporosis

Efficacy of strontium ranelate on bone mineral density in men with osteoporosis

by Ringe, Johann D, Dorst, Alfred, Farahmand, Parvis
Published in Arzneimittel-Forschung (01.01.2010)

Get more information

Journal Article

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: Results from the 24-week extension of a 15-week randomized, controlled trial

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: Results from the 24-week extension of a 15-week randomized, controlled trial

by Binkley, Neil, Ringe, Johann D, Reed, John I, Ljunggren, Östen, Holick, Michael F, Minne, Helmut W, Liu, Minzhi, Lamotta, Amy, West, Joseph A, Santora, Arthur C
Published in Bone (New York, N.Y.) (01.04.2009)

Get full text

Journal Article

Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses

Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses

by Ringe, Johann D., Schäfer, Susanne, Wimmer, Antonie M., Giesecke, Thorsten
Published in Wiener Klinische Wochenschrift (2012)

Get full text

Journal Article

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

by Ringe, Johann D, Farahmand, Parvis
Published in Clinical rheumatology (01.04.2007)

Get full text

Journal Article

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis

by Ringe, Johann D, Faber, Herbert, Fahramand, Parvis, Schacht, Erich
Published in Journal of rheumatology. Supplement (01.09.2005)

Get more information

Journal Article

Zoledronic acid in the treatment of Paget's disease and other benign bone disorders

Zoledronic acid in the treatment of Paget's disease and other benign bone disorders

by Ringe, Johann D
Published in Expert review of endocrinology & metabolism (01.01.2006)

Get full text

Journal Article